A PHASE Ib STUDY EVALUATING COBIMETINIB PLUS ATEZOLIZUMAB IN PATIENTS WITH ADVANCED BRAFV600 WILD-TYPE MELANOMA WHO HAVE PROGRESSED DURING OR AFTER TREATMENT WITH ANTI¿PD-1 THERAPY
Research Grant
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
March 17, 2017
End Date
February 28, 2020
Awarded By
F. Hoffmann-La Roche Ltd
Start Date
March 17, 2017
End Date
February 28, 2020